Atlas ICBM First Deployment: "Vandenberg Aerospace Air Force Base" 1959 US Air Force
more at http://scitech.quickfound.net/ "This 1959 film was produced by the U.S. Air Force to document the first operational deployment of the Atlas ICBM at V...
By: Jeff Quitney
Go here to read the rest:
Atlas ICBM First Deployment: "Vandenberg Aerospace Air Force Base" 1959 US Air Force - Video
Maintenance Can Protect Your Car #39;s Longevity: Car Expert Lauren Fix
Buying a new car may not be an option, but there #39;s no reason why almost any late-model car or truck can #39;t be counted on to last for ten or more years and run...
By: Lauren Fix
Link:
Maintenance Can Protect Your Car's Longevity: Car Expert Lauren Fix - Video
NATICK, Mass., May 10, 2013 /PRNewswire/ --New data from 100,438 patients with Boston Scientific Corporation (BSX) implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) followed in the LATITUDE Patient Management System demonstrate the battery life of Boston Scientific single-chamber ICDs, dual-chamber ICDs and CRT-Ds are projected to last an average of 13.2, 11.5 and 9.2 years, respectively.[1]
"Clinical studies show early device replacement brings an increased risk of infection and complications,[2],[3],[4],[5],[6],[7]" said Joe Fitzgerald, president, Cardiac Rhythm Management, Boston Scientific. "A nine-year average projected longevity of our CRT-Ds reflects our commitment to quality and engineering excellence. Our advances in device longevity also help reduce healthcare costs through fewer replacement surgeries due to battery depletion."
Introduced in 2008, the Boston Scientific current devices are the world's thinnest ICDs and CRT-Ds, with nearly twice the industry-standard battery capacity. In addition, the Boston Scientific INCEPTA CRT-D and ENERGEN ICD offer the industry's longest warranty, lasting up to 10 years for some models.[8]
"While device longevity is vital to customers and patients, we believe reliability is equally important," said Kenneth Stein, M.D., chief medical officer, Cardiac Rhythm Management, Boston Scientific. "We have paired our long-lasting ICDs and CRT-Ds with the RELIANCE defibrillator lead, which was designed to address the common issues facing ICD leads. The reliability of the Boston Scientific ENDOTAK RELIANCE defibrillator lead family is unmatched in the industry."
The ENDOTAK RELIANCE family of leads has nearly twenty years of proven performance. In fact, the ENDOTAK RELIANCE family of leads has a 98.5 percent survival probability at 10 years[9] which is better than the five-year or less survival probability of commonly used competitors' leads[10],[11]. The foundation of the reliability of the ENDOTAK RELIANCE has been its integrated bipolar design, abrasion-resistant silicone insulation and the unique GORE ePTFE coating that only Boston Scientific offers to patients and their physicians.
"The longer we can keep patients out of the hospital the better," added Dr. Stein. "The combination of industry-leading device longevity coupled with lead reliability provides a tangible benefit to patients. This is yet another example of our commitment to meaningful innovation and providing solutions that improve patient quality of life."
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit http://www.bostonscientific.com and connect on Twitter and Facebook.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding product performance and impact, our business plans and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.
Go here to read the rest:
Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To ...
Beijing, China (PRWEB) May 11, 2013
Puhua International Hospitals (PIHs)-Temple of Heaven (http://www.puhuahospital.com), (http://www.puhuachina.com) has been a leading international neuroscience and biotechnology center in Beijing, China, for the past 20 years. During that time, Puhua International has achieved a dominant presence in Beijing, China, in applied biotechnology, cellular biotherapy, neurology, neurosurgery, medicine, cancer, traditional Chinese medicine (TCM) and surgery.
Puhua International is the only international hospital in Beijing to routinely evaluate, treat and admit a wide range of international patients. In fact, Puhua International was one of the first of what are now known as medical tourism facilities in Asia, and the level of expertise and care for all international patients is currently unrivaled. Patients repeatedly report in quality-control surveys that the International Service Department at Puhua International is unrivaled for quality and outstanding level of no-problems service. Patients come to this hospital with diagnoses ranging from metabolic, genetic and genetic disorders to central nervous system (brain and spinal cord) injury and trauma; glioma; seizure disorders; cerebral palsy; Parkinson's disease and a wide range of neuropathic and myopathic disorders. PIH also has vigorous programs of integrative oncology and diabetes.
Over the past decade Puhua International Hospitals-Temple of Heaven has made huge strides forward in applied cellular biotechnology (stem cell therapy, or SCT). Thus, in addition to its high level of diagnostic and therapeutic expertise, PIH has become a world leader in applied biotechnology, cellular science and applied stem cell technology. It is in these areas of applied clinical biotechnology that remarkable progress is being made at PIH in the areas of: spinal cord repair; post-traumatic brain injury; cerebral palsy; Parkinsons disease; cerebral-vascular and cardio-vascular disease, and diabetes. Other conditions managed at PIH include the management of difficult tumors and cancers, metabolic diseases and genetic disorders. By utilizing cellular/regenerative medicine and biotechnology at the time of surgical repair for spinal cord and brain injury, the neurosurgeons and clinical scientists at PIH are today redefining what is possible in recovery from neurological injury and disease.
Whereas traditional SCT utilizes donor cell-lines (for example, mesenchymal stem cells derived from donor placental cord blood), newer pathways using autologous stem cells (meaning stem cell lines derived from the patients own cells) are now also being successfully employed. Autologous stem cellular therapy is extremely safe and cost-effective for younger (under 40 years of age) patients with diagnoses such as: cerebral palsy, anoxic encephalopathy, autism, diabetes and many other problems.
Puhua International Hospitals-Temple of Heaven, Beijing (http://www.puhuahospital.com) (http://www.puhuachina.com) is thus a Center of Excellence in neurology and neurosurgery as well as a leader on the new frontier of applied stem cell science and biotechnology.
James T. Quinlan, MD, is an American physician, trained at the University of Iowa, with a life-long interest and commitment to the subject of wellness, regenerative medicine and anti-aging. He is heading the international initiative at Puhua International Hospitals (PIH)-Temple of Heaven. The goal is to apply what has been learned in the past decade of applied stem cell science to the important and fascinating frontiers of anti-aging/regenerative medicine, diabetes, heart failure and cancer as well as the range of neurologic, metabolic and genetic diseases.
It is toward the goal of expanding its world-wide referral base that Puhua International Hospitals (PIHs)-Temple of Heaven announces its request that serious and suitable candidates who are interested in serving as international referring agents to PIHs submit their Bio and/or CV to info(at)puhuachina(dot)com for evaluation and consideration. A pre-requisite to become a Puhua International Partner is a Bachelors Degree (or higher) and experience in a health-related field. Special consideration will be given to those candidates who possess medical backgrounds and/or experience. Valued attributes include a high level of inter-personal skills, facility with marketing concepts/experience and polished communication skills.
The Puhua International Partnership seeks greater presence in Africa, the Americas, Asia, Europe, India, South East Asia and the U.K. All training and orientation for these positions will be undertaken and underwritten by Puhua International Hospitals (PIH)-Temple of Heaven. Individuals who are already positioned to understand stem cell science, and who are also in a position to reach out through their local and regional media to patients most likely to benefit from advanced cellular therapy are encouraged to contact us at info(at)puhuachina(dot)com.
After many treating many thousands of patients with mesenchymal stem cells, we know that this technique is safe and generally effective, and the stem cells themselves are the stars in this process. Their extremely low antigenicity coupled with their predilection to go to where they are needed, blend in with the hosts own (and older) stem cells and then go on to differentiate in harmony with these older cells makes the technical aspects of this process very straight-forward. Still, not every question has been answered. Thus, while offering an anti aging and many other stem cell therapies, Puhua International is also coupling these treatments to prospective clinical studies in the search to expand medical knowledge.
Continued here:
Puhua International Hospitals (PIHs): Soliciting Agents for World-wide Referral Network
A team of 70 scientists from the United States, China, Australia and Japan reports having sequenced and annotated the genome of the "sacred lotus," which is believed to have a powerful genetic system that repairs genetic defects, and may hold secrets about aging successfully.
The scientists sequenced more than 86 percent of the nearly 27,000 genes of the plant, Nelumbo nucifera, which is revered in China and elsewhere as a symbol of spiritual purity and longevity.
"The lotus genome is an ancient one, and we now know its ABCs," said Jane Shen-Miller, one of three corresponding authors of the research and a senior scientist with UCLA's Center for the Study of Evolution and the Origin of Life. "Molecular biologists can now more easily study how its genes are turned on and off during times of stress and why this plant's seeds can live for 1,300 years. This is a step toward learning what anti-aging secrets the sacred lotus plant may offer."
The research was published today in the journal Genome Biology.
Shen-Miller said the lotus' genetic repair mechanisms could be very useful if they could be transferred to humans or to crops such as rice, corn and wheat whose seeds have life spans of only a few years. "If our genes could repair disease as well as the lotus' genes, we would have healthier aging. We need to learn about its repair mechanisms, and about its biochemical, physiological and molecular properties, but the lotus genome is now open to everybody."
In the early 1990s, Shen-Miller led a UCLA research team that recovered a viable lotus seed that was almost 1,300 years old from a lake bed in northeastern China. It was a remarkable discovery, given that many other plant seeds are known to remain viable for just 20 years or less.
In 1996, Shen-Miller led another visit to China. Working in Liaoning province, her team collected about 100 lotus seeds - most were approximately 450 to 500 years old - with help from local farmers. To the researchers' surprise, more than 80 percent of the lotus seeds that were tested for viability germinated. That indicated that the plant must have a powerful genetic system capable of repairing germination defects arising from hundreds of years of aging, Shen-Miller said.
Understanding how the lotus repair mechanism works and its possible implications for human health is essentially a three-step process, said Crysten Blaby-Haas, a UCLA postdoctoral scholar in chemistry and biochemistry and co-author of the research. "Knowing the genome sequence was step one. Step two would be identifying which of these genes contributes to longevity and repairing genetic damage. Step three would be potential applications for human health, if we find and characterize those genes. The genome sequence will aid in future analysis.
"The next question is what are these genes doing, and the biggest question is how they contribute to the longevity of the lotus plant and its other interesting attributes," Blaby-Haas said. "Before this, when scientists studied the lotus, it's almost as if they were blind; now they can see. Once you know the repertoire of genes, you have a foundation to study their functions."
The genome sequence reveals that, when compared with known gene sequences of dozens of other plants, the lotus bears the closest resemblance to the ancestor of all eudicots, a broad category of flowering plants that includes the apple, peanut, tomato, cotton, cactus and tobacco plants.
Read the original post:
Genome of lotus may hold anti-aging secrets
By: Extropia DaSilva
One question that I have seen repeatedly asked is: When did the transhuman era begin; indeed, has it begun or is it an event that is yet to occur?
One can find arguments both for and against it being an event we are in the midst of. Those who argue in favour of the transhuman era being well underway argue that we are already cyborg: We compensate for short-sightedness with eyeglasses; we wear clothes to protect our body from the elements, and we depend greatly on computing and communications devices to organise our daily lives. Those who argue against point out that, while we are clearly dependent on technology, by and large it serves only to compensate for disabilities. Glasses correct short-sightedness, for example, but do not augment vision to human+ levels. And we merely carry our smart phones around with us, rather than have them implanted. We are not really cyborgs.
So what side of this argument do I side with? I think it pretty obvious that we are in the midst of the transhuman era. We are, now, clearly in a transitional period between homo-sapiens sapiens and the post-human. It is not my purpose to pinpoint when, exactly, the transhuman era began. Perhaps it is impossible to pinpoint the moment when our relationship with technology was such that we had become transhuman. The computer age? The Industrial Age? The Stone Age? I would not be surprised if arguments could be made favouring any one as the age in which our relationship with technology was intimate enough to warrant favouring it as the beginning of the transhuman era. What I want to show is that, it began at some hard-to-define period in the past and we are now well into that transitional period between natural humans and whatever technological being is to follow.
Consider the range of our senses and physical abilities as natural humans*:
Visible light: 4 to 7 times 10^-5 meters.
Hearing: 10 to 20,000 Hz
Chemosenses: 5 tastes, 1000 smells
Touch: 3,000nm
Heat sensing 200 to 400K
Visit link:
NewsLife Interview: Dr. Theresa Deischer, Founder, SCPI- benefits and effects of stem cell therapy
NewsLife Interview: Dr. Theresa Deischer, Founder, Sound Choice Pharmaceutical Institute - benefits and effects of stem cell therapy - [May 7, 2013] For more...
By: PTV PH
Visit link:
Adapting Buddhist Meditation Practices to Christian Spirituality - by Susan Stabile
Jay Phillips Center presentation by Susan Stabile: Adapting Buddhist Meditation Practices to Christian Spirituality Novemeber 12th, 2013 Q264, Saint John #39;s U...
By: CSBSJUDigitalCommons
Originally posted here:
Adapting Buddhist Meditation Practices to Christian Spirituality - by Susan Stabile - Video
Marissa To me spirituality is...
By: StillHarborVideos
More here:
Meghan To me spirituality is...
By: StillHarborVideos
Here is the original post:
StanleyRTo me spirituality is...
By: StillHarborVideos
Read more:
Kerbal Space Program - Modular Space Station Completed - Example
This space station in a remake of the Mir Space Station using stock parts form Kerbal Space Program. Game: The game Kerbal Space program was created by Squad...
By: GameplayReviewUK
Read this article:
Kerbal Space Program - Modular Space Station Completed - Example - Video
Let #39;s Fly Kerbal Space Program: series 2, ep.23, First Space Station Module
I #39;m going to need a space station for future plans. This episode documents the design and launch of the first component. Get the game here: https://kerbalspa...
By: TheWinterOwl
View post:
Let's Fly Kerbal Space Program: series 2, ep.23, First Space Station Module - Video
Star Trek The Video Game - Part 1 - Vulcan Space station - Kirk - Hard
Star Trek The Video Game Playthrough as Kirk on a epic adventure with Spock as his trusted side kick. We begin by having to bail out some as always arrogant ...
By: Jacdk
Go here to see the original:
Star Trek The Video Game - Part 1 - Vulcan Space station - Kirk - Hard - Video
Spacewalks Needed To Repair Space Station Cooling System In 2010 | Video
Three spacewalks were conducted by Expedition 24 Flight Engineers Doug Wheelock and Tracy Caldwell Dyson to remove and replace a failed ammonia pump that disabled one of the station #39;s 2 cooling...
By: VideoFromSpace
Excerpt from:
Spacewalks Needed To Repair Space Station Cooling System In 2010 | Video - Video
Space Station Ammonia Leak Seen By Exterior Camera | Video
Droplets of liquid are seen floating out the the International Space Station on May 10th, 2013. The leak is emanating from the station #39;s P6 truss.
By: VideoFromSpace
Read the original post:
Space Station Ammonia Leak Seen By Exterior Camera | Video - Video
Astronauts on the International Space Station are gearing up to perform a potential emergency spacewalk Saturday (May 11) to hunt for an ammonia leak in the orbiting laboratory's cooling system.
NASA astronauts Tom Marshburn and Chris Cassidy are planning to spend more than six hours outside the station to find, and possibly repair, the ammonia coolant leak.
The spacewalk will come two days after the six-man crew of the space station noticed frozen flakes from an ammonia leak on one of the eight wing-like solar arrays responsible for supplying power to the station. Planning a space station spacewalk repair in such a fast timeframe is unprecedented, NASA officials said. [How the Space Station's Cooling System Works (Infographic)]
It also comes just two days before Marshburn and two crewmates, station commander Chris Hadfield of Canada and Russian cosmonaut Roman Romanenko, are due to return home on Monday, May 13. The departures and arrivals of the crewmembers will not be affected by the spacewalk, NASA officials said.
The space station crew is in no danger, and the pump has been turned off in order to slow the rate of leaking coolant, mission managers said. The leak is on the space station's Port 6 truss, at the leftmost side of the outpost's football field-length main truss.
"[The] objective is to get a look at the leak," Mike Suffredini, NASA's International Space Station program manager said of the spacewalk during a briefing today.
Spacewalk repair on tap
A team of NASA officials will meet later tonight to make an final decision whether to proceed with the spacewalk. If approved, the excursion will begin early Saturday at 7:15 a.m. EDT (1115 GMT).
The spacewalk will air live on NASA TV beginning at 7 a.m. EDT (1100 GMT). You can watch the webcast live on SPACE.com, courtesy of NASA.
If the spacewalk does go forward, Cassidy and Marshburn will float outside of the station to inspect the leaking loop. The two astronauts will then attempt to replace an ammonia coolant pump that station engineers suspect may be the location of the leak, NASA officials said.
Read the original here:
Astronauts Set for Emergency Spacewalk to Fix Space Station Leak
MIAMI (Reuters) - NASA plans to send two astronauts aboard the International Space Station out on a spacewalk on Saturday to try to fix an ammonia leak in a cooling system on one of the station's solar arrays, the U.S. space agency said on Friday.
The crew spotted a steady stream of small, white frozen ammonia flakes floating away from a coolant line outside the orbital outpost on Thursday.
Mission managers reviewed images and data gathered overnight and said on Friday they tentatively planned to send American astronauts Chris Cassidy and Tom Marshburn out on Saturday morning to try to stop the leak by replacing a pump on the cooling system.
"The crew is not in danger, and the station continues to operate normally otherwise," NASA said in a news release.
Ammonia is used to cool the power systems that operate the solar arrays, which provide electricity to the station. Each of the eight solar arrays has its own independent cooling system.
The leak is on the far left side of the station's truss structure, in an ammonia loop that astronauts previously tried to troubleshoot during a spacewalk in November 2012.
While Cassidy and Marshburn are working outside the space station, crew commander Chris Hadfield, a Canadian astronaut, will choreograph their movements from inside the orbital outpost. Russian cosmonauts Pavel Vinogradov, Alexander Misurkin and Roman Romanenko make up the rest of the crew.
Work was under way to reroute the remaining power channels to maintain full operation of the systems normally controlled by the solar array that is cooled by the leaking loop.
The space station, a $100 billion research laboratory that orbits 250 miles above Earth, is owned by the United States and Russia in partnership with Europe, Japan and Canada.
(Reporting by Jane Sutton; Editing by Vicki Allen and Philip Barbara)
Excerpt from:
On Saturday NASA will try to fix the leak that released a stream of white frozen flakes into space. The crew on the International Space Station is not in danger and the space station is continuing to operate normally. NBC's Brian Williams reports.
By Miriam Kramer Space.com
Astronauts on the International Space Station are gearing up to perform an emergency spacewalk Saturday to hunt for an ammonia leak in the orbiting laboratory's cooling system.
NASA astronauts Tom Marshburn and Chris Cassidy are planning to spend more than six hours outside the station to find, and possibly repair, the ammonia coolant leak.
The spacewalk comes just two days after the six-man crew of the space station noticed frozen flakes from an ammonia leak on one of the eight winglike solar arrays responsible for supplying power to the station. Planning a space station spacewalk repair in such a short time frame is unprecedented, NASA officials said. [Infographic: How the Space Station's Cooling System Works]
It also comes just two days before Marshburn and two crewmates, station commander Chris Hadfield of Canada and Russian cosmonaut Roman Romanenko, are due to return home. Monday's departure will not be affected by the spacewalk, NASA officials said.
The space station crew is in no danger, and the pump has been turned off in order to slow the rate of the leak, mission managers said. The leak is on the space station's P6 truss, at the leftmost side of the outpost's football field-length main truss.
NASA's space station program manager, Mike Suffredini, said the spacewalk's "objective is to get a look at the leak."
Spacewalk repair on tap A team of NASA officials gave the go-ahead late Friday for the spacewalk to begin at 8:15 a.m. ET Saturday. The plan calls for Cassidy and Marshburn to float outside of the station to inspect the leaking loop. Then they'll try to replace an ammonia coolant pump that station engineers suspect may be the source of the leak.
Marshburn and Cassidy have both conducted three spacewalks two of them together during their 2009 mission on the space shuttle Endeavour. This spacewalk is expected to take a little more than six hours. "The crew is very familiar in this area," Norm Knight, NASA chief flight director, said during a briefing on Friday. This type of repair, however, is unprecedented in the space station's history, he added.
The rest is here:
Spacewalkers set to troubleshoot space station's ammonia coolant leak